Vireo Growth (VREOF) Interest Expenses (2020 - 2026)
Vireo Growth (VREOF) posted Interest Expenses of $258.9 million for Q1 2026, up 867.36% sequentially from $26.8 million in Q4 2025, and up 3306.8% YoY from $7.6 million in Q1 2025.
Vireo Growth (VREOF) Interest Expenses (2020 - 2026) Analysis & Trends
Vireo Growth has reported Interest Expenses for 7 years, with the latest figure at $258.9 million in Q1 2026.
- Quarterly Interest Expenses rose 3306.8% year-over-year to $258.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.9 million (up 981.0% YoY) and the FY2025 annual result came in at $28.6 million, down 10.45% from the prior year.
- Interest Expenses grew to $258.9 million in Q1 2026 per VREOF's latest filing, from $26.8 million in the prior quarter.
- Over five years, Interest Expenses peaked at $283.0 million in Q2 2024 and troughed at $2.2 million in Q4 2023.
- A 5-year average of $74.2 million and a median of $16.2 million in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses tumbled 97.83% in 2022, then soared 3511.12% in 2025.
- Over 5 years, Interest Expenses stood at $7.1 million in 2022, then sank by 69.52% to $2.2 million in 2023, then jumped by 214.04% to $6.8 million in 2024, then surged by 292.63% to $26.8 million in 2025, then soared by 867.36% to $258.9 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $258.9 million, $26.8 million, and $265.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Vireo Growth | 493.25 Mn | 350.95 Mn | 95.30 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 258.90 Mn |
| Mar 31, 2026 | 258.90 Mn |
| Dec 31, 2025 | 26.76 Mn |
| Dec 31, 2025 | 26.76 Mn |
| Sep 30, 2025 | 265.91 Mn |
| Sep 30, 2025 | 265.91 Mn |
| Jun 30, 2025 | 61.05 Mn |
| Jun 30, 2025 | 61.05 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 6.82 Mn |
| Dec 31, 2024 | 6.82 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Jun 30, 2024 | 282.96 Mn |
| Jun 30, 2024 | 282.96 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Dec 31, 2023 | 2.17 Mn |